tradingkey.logo

Harvard Bioscience Inc

HBIO
0.495USD
+0.023+4.92%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
22.08MCap. mercado
PérdidaP/E TTM

Harvard Bioscience Inc

0.495
+0.023+4.92%

Más Datos de Harvard Bioscience Inc Compañía

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Información de Harvard Bioscience Inc

Símbolo de cotizaciónHBIO
Nombre de la empresaHarvard Bioscience Inc
Fecha de salida a bolsaOct 21, 2013
Director ejecutivoDuke (John D)
Número de empleados330
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 21
Dirección84 October Hill Rd
CiudadHOLLISTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01746-1371
Teléfono15088938999
Sitio Webhttps://www.harvardbioscience.com/
Símbolo de cotizaciónHBIO
Fecha de salida a bolsaOct 21, 2013
Director ejecutivoDuke (John D)

Ejecutivos de Harvard Bioscience Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
311.13K
-110000.00%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
110.00K
+110000.00%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
+87289.00%
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert Benson
Mr. Robert Benson
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
311.13K
-110000.00%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
110.00K
+110000.00%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
+87289.00%
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Instruments, equipment, software and accessories
18.58M
90.24%
Service, maintenance and warranty contracts
2.01M
9.76%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
9.25M
44.94%
Europe, Middle East and Africa
6.61M
32.10%
China
2.15M
10.42%
Rest of Asia
1.40M
6.78%
Americas - Other
1.19M
5.75%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Instruments, equipment, software and accessories
18.58M
90.24%
Service, maintenance and warranty contracts
2.01M
9.76%

Estadísticas de accionistas

Actualizado: dom., 1 de feb
Actualizado: dom., 1 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
AMH Equity, Ltd.
7.49%
Weber Capital Management, LLC
7.16%
Green (James W)
4.65%
Harvey Partners, LLC
4.58%
The Vanguard Group, Inc.
4.30%
Otro
71.82%
Accionistas
Accionistas
Proporción
AMH Equity, Ltd.
7.49%
Weber Capital Management, LLC
7.16%
Green (James W)
4.65%
Harvey Partners, LLC
4.58%
The Vanguard Group, Inc.
4.30%
Otro
71.82%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
17.62%
Investment Advisor
11.55%
Investment Advisor/Hedge Fund
9.16%
Individual Investor
8.73%
Venture Capital
7.16%
Pension Fund
2.03%
Research Firm
0.15%
Family Office
0.07%
Bank and Trust
0.01%
Otro
43.52%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
197
21.17M
47.34%
-11.22M
2025Q3
201
25.97M
58.27%
-8.70M
2025Q2
214
34.64M
78.35%
-7.01M
2025Q1
216
35.57M
80.46%
-4.66M
2024Q4
216
39.38M
90.28%
+2.67M
2024Q3
217
37.20M
85.38%
-773.14K
2024Q2
216
36.12M
83.22%
-2.57M
2024Q1
216
36.60M
84.34%
-2.39M
2023Q4
219
36.53M
85.65%
-2.57M
2023Q3
223
36.90M
86.54%
-1.23M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
AMH Equity, Ltd.
4.05M
9.09%
+538.83K
+15.36%
Aug 06, 2025
Weber Capital Management, LLC
3.20M
7.19%
+683.45K
+27.15%
Mar 31, 2025
Green (James W)
1.64M
3.68%
-392.52K
-19.34%
Aug 15, 2025
Harvey Partners, LLC
2.14M
4.81%
-46.40K
-2.12%
Jun 30, 2025
The Vanguard Group, Inc.
1.85M
4.16%
-284.86K
-13.32%
Jun 30, 2025
272 Capital LLC
1.56M
3.49%
+1.56M
--
Sep 30, 2024
Acadian Asset Management LLC
1.04M
2.33%
-37.84K
-3.51%
Jun 30, 2025
Duke (John D.)
1.00M
2.25%
+1.00M
--
Aug 08, 2025
Meros Investment Management, LP
919.95K
2.07%
+125.27K
+15.76%
Jun 30, 2025
Florida State Board of Administration
910.00K
2.04%
+130.66K
+16.77%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Franklin US Small Cap Multifactor Index ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Lattice Hartford Multifactor Small Cap ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Proshares Ultra Russell 2000
0%
Ver más
Franklin US Small Cap Multifactor Index ETF
Proporción0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0%
Lattice Hartford Multifactor Small Cap ETF
Proporción0%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0%
ProShares Hedge Replication ETF
Proporción0%
ProShares UltraPro Russell2000
Proporción0%
iShares Russell 2000 Growth ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI